These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1970485)

  • 1. Neuroleptic-associated autoantibodies. A prevalence study.
    Canoso RT; de Oliveira RM; Nixon RA
    Biol Psychiatry; 1990 Apr; 27(8):863-70. PubMed ID: 1970485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors related to the presence of autoantibodies in patients with chronic mental disorders.
    Yannitsi SG; Manoussakis MN; Mavridis AK; Tzioufas AG; Loukas SB; Plataris GK; Liakos AD; Moutsopoulos HM
    Biol Psychiatry; 1990 Apr; 27(7):747-56. PubMed ID: 2328270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibodies in chronic psychotic patients treated with chlorpromazine.
    Quismorio FP; Bjarnason DF; Kiely WF; Dubois EL; Friou GJ
    Am J Psychiatry; 1975 Nov; 132(11):1204-6. PubMed ID: 52302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.
    Scott-Morgan L; Lloyd RS
    Clin Exp Immunol; 1980 Aug; 41(2):297-302. PubMed ID: 6160005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear autoantibodies in chronic schizophrenia.
    Spivak B; Radwan M; Bartur P; Mester R; Weizman A
    Acta Psychiatr Scand; 1995 Oct; 92(4):266-9. PubMed ID: 8848951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptics and the neuroleptic-induced deficit syndrome.
    Lewander T
    Acta Psychiatr Scand Suppl; 1994; 380():8-13. PubMed ID: 7914056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
    Gallien M; Schnetzler JP; Morin J
    Ann Med Psychol (Paris); 1975 Feb; 1(2):237-48. PubMed ID: 9021
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity of laboratory test results for antiphospholipid antibodies in patients treated with chlorpromazine and other phenothiazines.
    Lillicrap DP; Pinto M; Benford K; Ford PM; Ford S
    Am J Clin Pathol; 1990 Jun; 93(6):771-5. PubMed ID: 1971739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic drugs and trophic disorders].
    Vitorović M; Kobalova M
    Nervenarzt; 1984 Jan; 55(1):51-3. PubMed ID: 6143272
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.
    Shokri F; Mageed RA; Kitas GD; Katsikis P; Moutsopoulos HM; Jefferis R
    Clin Exp Immunol; 1991 Jul; 85(1):20-7. PubMed ID: 2070558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotic patients who become worse on neuroleptics.
    Bowers MB; Swigar ME
    J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.
    Chengappa KN; Carpenter AB; Keshavan MS; Yang ZW; Kelly RH; Rabin BS; Ganguli R
    Biol Psychiatry; 1991 Oct; 30(7):731-5. PubMed ID: 1683585
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics.
    Bloom D; Krishnan B; Thavundayil JX; Lal S
    Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody profiles in juvenile arthritis.
    Haynes DC; Gershwin ME; Robbins DL; Miller JJ; Cosca D
    J Rheumatol; 1986 Apr; 13(2):358-63. PubMed ID: 3487649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorpromazine-associated antiphospholipid antibody syndrome.
    Iyer HV; Moudgil H; Newman P; Srinivasan KS
    Ann Pharmacother; 2007 Mar; 41(3):528. PubMed ID: 17341541
    [No Abstract]   [Full Text] [Related]  

  • 17. The medical-pharmacological management of acute psychoses.
    Young LD
    J S C Med Assoc; 1975 Sep; 71(9):274-81. PubMed ID: 241877
    [No Abstract]   [Full Text] [Related]  

  • 18. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
    Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
    J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
    Monti M; Borgognoni F; Pastacci L; Vincentelli GM
    G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
    Gulez N; Karaca NE; Aksu G; Kutukculer N
    Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.